Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.22.1
Equity Incentive Plan (Tables)
 3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense
   

Three Months Ended
March 31,

(unaudited)

  
(in thousands)    2022     2021  
General and administrative   $ 310     $ 217  
Sales and marketing     28       41  
Research and development     65       71  
Cost of revenues     21       55  
    $ 424     $ 384  

 
Schedule of fair value of option grants weighted average assumptions
   

Three Months Ended
March 31,

(unaudited)

  
    2022     2021  
Expected term (in years)     5.9       5.8  
Expected volatility     54.4 %     54.5 %
Risk-free rate     1.9 %     0.8 %
Dividend rate    
—
      
—
  

 
Schedule of stock option activity
   

Number of

Shares under

Option Plan

     Weighted-
Average
Exercise
Price per
Option		    

Weighted-

Average

Remaining

Contractual

Life
(in years)

  
Outstanding at December 31, 2021     6,583,381     $        1.78       8.0  
Granted     1,567,524     $ 2.41          
Exercised     (26,317 )   $ 0.71          
Forfeited and expired     (30,044 )   $ 3.09          
Outstanding at March 31, 2022     8,094,544     $ 1.90       8.2  
Exercisable at March 31, 2022     4,046,011     $ 1.18       7.6  
Vested and expected to vest at March 31, 2022     8,094,544     $ 1.90       8.2